Two MedTech giants, one non-compete clause, and relationships nobody could prove existed
A Singapore court has refused to stop a former Boston Scientific director from working at rival Johnson & Johnson.
The decision, delivered on October 1, 2026, denied Boston Scientific Asia Pacific's bid for an interim injunction - essentially a court order to pull its former electrophysiology chief out of his new job at J&J while the companies' broader legal fight plays out.
Both Boston Scientific and J&J are heavyweights in the medical technology space, competing directly in electrophysiology - a branch of cardiology focused on the heart's electrical system. Boston Scientific says it was the first MedTech manufacturer to bring pulsed field ablation technology to the field.
The employee at the centre of the dispute had held the role of Commercial Director for Electrophysiology across the Asia-Pacific region. Boston Scientific described him as its "most senior EP executive in the Asia Pacific region," responsible for marketing, portfolio management, clinical and regulatory strategy, and physician education programmes, among other functions.
His contract included a 12-month non-compete clause. In return for staying out of competing work, Boston Scientific would continue paying his monthly base pay for the entire restricted period.
He gave notice of his resignation on June 22, 2026, telling Boston Scientific's Chief Human Resources Officer and General Counsel that he planned...
Read Full Story:
https://news.google.com/rss/articles/CBMiygFBVV95cUxQMTJrNGNud1lXaENJWVhmX1Jx...